The need for asthma phenotyping

S. Saglani (London, United Kingdom)

Source: International Congress 2018 – PG17 Asthma phenotyping
Session: PG17 Asthma phenotyping
Session type: Postgraduate Course
Number: 189
Disease area: Airway diseases

WebcastSlide presentation

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Saglani (London, United Kingdom). The need for asthma phenotyping. International Congress 2018 – PG17 Asthma phenotyping

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Erik Guilherme De Lemos Macedo - 25.02.2019 21:21
Great presentation!

Erik Guilherme De Lemos Macedo - 25.02.2019 21:20
Audio not so good.
You must Login to comment this presentation.


Related content which might interest you:
Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD
Source: Eur Respir J 2013; 42: 891-892
Year: 2013


Ykl-40 and phenotyping of severe asthma
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019


Potential usefulness of phenotyping in asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Is there a need for pharmacoepidemiology in asthma and COPD?
Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials
Year: 2004

Role of biomarkers in the assessment and phenotyping asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Do we need new asthma control tests?
Source: Eur Respir J 2014; 44: 1116-1118
Year: 2014


Do we need new therapies for noneosinophilic asthma?
Source: Annual Congress 2004 - Noneosinophilic asthma
Year: 2004

A novel asthma monitoring system for asthma management in children
Source: Annual Congress 2005 - Monitoring paediatric asthma
Year: 2005


Examining the unmet need in inadequately controlled severe allergic asthma
Source: Annual Congress 2004 - Anti-IgE: Addressing the unmet need in inadequately controlled severe allergic asthma
Year: 2004

Diagnostic approach to and phenotyping of severe asthma
Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma
Year: 2017


Metabolic profiling of severe asthma: implications for phenotyping and treatment
Source: ERS Lung Science Conference 2020
Year: 2020

Characterization of CD4-endotypes in severe allergic asthma for future precision medicine
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

How to define asthma in large-scale studies?
Source: International Congress 2014 – Is asthma prevalence still increasing?
Year: 2014



Component-resolved allergy diagnostics identify phenotypes in problematic severe childhood asthma
Source: Annual Congress 2011 - Risk and detection of childhood asthma and allergy
Year: 2011

CD4cell profiling to support endotypical stratification of severe allergic asthma - an update
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019

The need for pre-treatment spirometry in suspected asthma
Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care
Year: 2008